The Alberta Kidney Disease Network (AKDN) and the University of Alberta are accepting applications for
a Fellowship in Chronic Kidney Disease Clinical Research, to be based in Edmonton, Alberta. The AKDN is
a collaborative network of Nephrology researchers located in the cities of Edmonton and Calgary in
Alberta, Canada. AKDN trainees and junior faculty have recently published papers as first authors in a
variety of major journals including JAMA, Annals of Internal Medicine, the American Journal of
Medicine, JASN, cJASN, Kidney International, and the American Journal of Kidney Disease (see
www.akdn.info for more information).
This two to four year Fellowship will train emerging leaders in clinical kidney disease research. Areas of
specific focus will include one or more of Clinical Epidemiology, Health Services Research, Clinical Trials,
Meta-analysis and Health Economics. Although preference will be given to those who hold advanced
(Masters level or higher) training in research methodology, qualified candidates may also choose to
pursue a first or additional graduate degree under the supervision of an AKDN faculty member.
We offer outstanding research mentorship, a wide variety of research projects, a collegial and
supportive working environment, and substantial (>80%) protected time for research. Fellows will be
free of clinical duties and on-call responsibilities except for six mandatory weeks of clinical service per
annum, which they will fulfill as junior attending physicians. Salary will be C$100,000 per annum plus
benefits (C$1 = US$1), and Fellows who hold external salary awards from outside agencies may be
eligible for an additional salary supplement. The AKDN will also consider partially funding the cost of
tuition for Fellows seeking to pursue a graduate degree during their Fellowship.
Edmonton is a vibrant metropolitan area of approximately 1M inhabitants, with excellent quality of life,
a low cost of living, and ample opportunities for outdoor recreation. Financial assistance with relocation
may be available for certain candidates.
Successful candidates will be fluent in English, have completed clinical training in Nephrology, and be
eligible for licensure as an internal medicine specialist in the province of Alberta (minimum of 4 years of
residency training following medical school). Outstanding and qualified applicants are encouraged to
apply, regardless of their current country of residence.
The starting date for Fellowships is flexible. Applications will be reviewed quarterly and the application
process is competitive. Interested individuals should contact:
Dr. Marcello Tonelli
Division of Nephrology, University of Alberta
mtonelli@ualberta.ca
Objectives and Aim of the Awards
To support two clinical research projects per annum in the area of kidney outcomes following transplantation. The scope includes clinical studies of organ (kidney, pancreas, liver, heart, lung or bone marrow) transplant recipients where the focus is on kidney-relevant outcomes, such as kidney function, anaemia or bone disease.
Funding
The two awards are for $50,000 each for one year.
Applications
The awards are open to all financial members of 12 months standing of the Transplantation Society of Australia and New Zealand (TSANZ).
Reporting
Successful applicants will be required to present an annual progress report to TSANZ until completion of the project and will be encouraged to present their findings at the TSANZ Annual Scientific Meeting.
Closing Date
A. 1 page letter of intent, A4 Arial 10 font, which should include an outline of the proposed project (rationale, aims, methods, expected outcome and impact) plus contact details, should be lodged with the Honorary Secretary of TSANZ by 5pm Friday 18th April 2008.
B. The 5 best applicants will be contacted by Friday 2nd May 2008, and full applications (3 A4 pages, Arial 10 font, including rationale, aims, methods, expected outcome and impact) together with Curriculum Vitae for 1-3 investigators, will be sought with the closing date being Monday 2nd June 2008.
C. Applicants will be advised of the outcome by Friday 1st August 2008, and the successful applicant will be formally announced and presented with their award at the TSANZ AGM on Thursday 14th August during the XXII International Congress of the Transplantation Society in Sydney.
Please email all applications to Aviva Rosenfeld tsanz@racp.edu.au
Purpose: To provide support for an Australian Indigenous Basic or Advanced Trainee in any of the specialist disciplines of the Royal Australasian College of Physician’s training programs.
Value: $6,000 per annum for each year of Training
Eligibility: Recipients must be Australian Indigenous medical practitioners currently undertaking training at the RACP at an accredited hospital or alternate training facility, or within another approved training program.
Selection will be based on:
The scholarship recipient should not normally hold any other scholarship or award except with the permission of the College steering committee.
Tenable: The scholarship will normally be tenable for the duration of the trainee program dependant on performance and academic progress.
The scholarship is made available by a grant from the Royal Australasian College of Physicians, Siggins Miller, an anonymous benefactor and A/Professor Noel Hayman.
APPLICATIONS CLOSE: 30th April 2008
For further information please email or phone the RACP Grants Administrator foundation@racp.edu.au T: 02 9256 9639
Information regarding JDRF Travel and Summer Student Grants are available from
CEO, JDFA, Level 4, 80-84 Chandos Street, St Leonards NSW 2065.
Phone: (02) 9966 0400 ext 201
Fax No: (02) 9966 0172
Email: vwilson@jdrf.org.au
Website: www.jdrf.org.au
Dr. Bernd Tersteegen, the founder of the Verband Deutsche Nierenzentren der DDnÄ e.V., was dedicated to the improvement of outpatient treatment modalities in end-stage renal disease. Specifically he focused on further technical development of hemodialysis. The Bernd Tersteegen award was established following the death of Dr. Tersteegen in 1995. The prize is awarded internationally both for basic and particularly for clinical research related to chronic renal insufficiency and to advances in treatment of end-stage renal disease.
The annual award of 8000 Euro is provided by the Roche Pharma AG (Grenzach, Germany). The award is usually given to a single applicant but may be shared under certain circumstances. Applicants should be physicians, researchers, or engineers who are involved in research in the area of renal failure and renal replacement therapy. Only research papers that have been published in 2007 or 2008 or have not yet been published are suitable for submission. Papers should be written in German or English. Review articles, dissertations, university habilitation works and manuscripts already entered in other competitions may not be submitted.
Groups of authors, who submit a work, must agree to the designation of a single speaker for the group. The written consent of all co-authors of a paper to the designation of the speaker must accompany the application. An abbreviated curriculum vitae and a list of publications to date should also be submitted.
Five copies of the work must be submitted by July 15, 2008 to the following address:
Verband Deutsche Nierenzentren der DDnÄ e.V.
Priv. Doz. Dr. med. Werner Kleophas, President
Kleine Klotzbahn 23
42105 Wuppertal
The members of the prize committee are chosen by the executive board of the DDnÄ. The president of the DDnÄ serves as chairman of the committee.
In the case in which no work is found suitable for the award, the prize money is carried over to the following year. An appeal is not allowed.
The award will be conferred at the Annual Meeting of the Association of German Nephrology Centers of the DDnÄ on November 22, 2008 in Mannheim, Germany. The presence of the award winner at the award ceremony is required. The award winner will be informed in due time.
Phone: 02 02 / 248 45 0
Fa
x: 02 02 / 248 45 60
Email:
info@dnev.de
Website:
www.dnev.de
